PDCD1 and Merkel cell skin cancer: Although MCC-specific T cells typically express inhibitory receptors targeted by immunotherapy (i.e., PD-1, CTLA-4, TIM-3, LAG-3), only about half of patients persistently respond to immune checkpoint inhibition (ICI).